chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Child was given vaccines as follows: Hepatitis A and PREVNAR in right deltoid Hep A upper and PREVNAR 1" lower and over, MMR upper left arm and VARIVAX 2" lower on upper left arm. Flu vaccine left anterior thigh. Hives developed immediately above MMR site.
Patient left the immunization area and returned immediately. He was disoriented and briefly passed out. He regained consciousness and was sweating. We placed a cold compress behind his neck and call 911. The paramedics arrived and did an assessment. The Patient refused to go to the hospital.
pt recvd vax & devel a fever to 105 which persisted for 5 days; also had intermittent lower abdo discomfort w/general malaise;
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 06-OCT-2015, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles (lot #, dose and route not provided). The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of shingles. On or about 08-DEC-2016, the patient was treated by a physician at a Family Medicine Center for the onset of blistery rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles. The patient was prescribed gabapentin for management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient has suffered and will continue to suffer significant medical expenses, lost wages, pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
I was unaware nursing staff already gave her the flu vaccine.  They brought her to me and asked for both flu and covid vaccines.  After the fact when reconciling records we noticed that nursing staff also gave the flu vaccine.  She received a duplicate flu vaccine.  Nursing staff were going to monitor for adverse effects and let me know if she developed side effects.
Pt received vaccinations on 4/12/00. Pt experienced bruising. Pt was dx with ITP and an initial platelet count 1000. Pt was transferred to another hospital and was treated with gamma globulin.
Pneumococcal polysaccharide 23-valent vaccine given on 11/17/16.  On 11/19/16, patient went to ED with c/o Right arm swelling and pain in R upper arm and shoulder.  Swelling has urticarial appearance with sharp border, mild redness overlying swelling; injection over proximal shoulder and without erythema or warmth.  Some pan with movement of R shoulder but good ROM.  No swelling of shoulder joint.  Pt has no fevers.  Reaction favors inflammatory reaction to vaccine, rather than cellulitis.  Treated with NSAIDS and antihistamines.
Mother stated the induration appeared about 24-hrs after receiving VZV vaccination and now is approximately the size of a quarter, red and warm to the touch, cold packs placed over site and given Tylenol for discomfort. Advised mother to continue watching site and continue home treatment plan. If condition worsens or she has more concerns she can contact their PCP or if site get larger or she has more concerns she can take her daughter to ER for additional Treatment during the weekend.
This spontaneous report as received from a Medical Assistant refers to a patient of unknown age and gender. On 05-AUG-2015, the patient was vaccinated with an improperly stored dose of (Oka/Merck) VARIVAX lot # L000454 with exp. 06-JAN-2017, (route and dos were not provided). No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to a patient of unknown demographics. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapy were not reported. On 17-JUL-2018, the patient was vaccinated with improperly stored doses of PROQUAD either from lot # R002939, expiry date: 29-JUL-2019 or lot # R006218, expiry date: 28-AUG-2019 (dose, frequency and route were not reported) for prophylaxis. Sterile diluent (MRK) was properly stored. No adverse effects were reported. No product quality complaint was involved. The PROQUAD was stored in temperature of 15 degree Fahrenheit (F) to 46 F for 14 hours on 16-JUN-2018. No previous temperature excursion was reported. A digital data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1808USA001261: US-009507513-1808USA004381: Original Case: 1808USA001261; US-009507513-1808USA004382: Original Case: 1808USA001261; US-009507513-1808USA004383: Original Case: 1808USA001261; US-009507513-1808USA004380: Original Case: 1808USA001261; US-009507513-1808USA004379: Original Case: 1808USA001261; US-009507513-1808USA004376: Original Case: 1808USA001261; US-009507513-1808USA004377: Original Case: 1808USA001261; US-009507513-1808USA004378: Original Case: 1808USA001261; US-009507513-1808USA004385: Original Case: 1808USA001261; US-009507513-1808USA004362: Original Case: 1808USA001261; US-009507513-1808USA004386: Original Case: 1808USA001261; US-009507513-1808USA004387: Original Case: 1808USA001261; US-009507513-1808USA004388: Original Case: 1808USA001261; US-009507513-1808USA004363: Original Case: 1808USA001261; US-009507513-1808USA004364: Original Case: 1808USA001261; US-009507513-1808USA004389: Original Case: 1808USA001261; US-009507513-1808USA004390: Original Case: 1808USA001261; US-009507513-1808USA004391: Original Case: 1808USA001261; US-009507513-1808USA004392: Original Case: 1808USA001261; US-009507513-1808USA004393: Original Case: 1808USA001261; US-009507513-1808USA004394: Original Case: 1808USA001261; US-009507513-1808USA004395: Original Case: 1808USA001261; US-009507513-1808USA004396: Original Case: 1808USA001261; US-009507513-1808USA004365: Original Case: 1808USA001261; US-009507513-1808USA004366: Original Case: 1808USA001261; US-009507513-1808USA004367: Original Case: 1808USA001261; US-009507513-1808USA004397: Original Case: 1808USA001261; US-009507513-1808USA004398: Original Case: 1808USA001261; US-009507513-1808USA004399: Original Case: 1808USA001261; US-009507513-1808USA004400: Original Case: 1808USA001261; US-009507513-1808USA004368: Original Case: 1808USA001261; US-009507513-1808USA004369: Original Case: 1808USA001261; US-009507513-1808USA004401: Original Case: 1808USA001261; US-009507513-1808USA004370: Original Case: 1808USA00126.
Patient received Moderan dose 1 vaccine and felt lightheaded, presyncopal and then reported numbness and tingling to the shoulder and trapezius muscle on the left, ipsilateral to the injection site.  She felt better after 30 minutes and proceeded to go eat in her bedroom.  She was nervous and anxious prior to the vaccine and states that she thought that had something to do with it.  She then experienced a 10 second bout of muscle tension in her face and jaw which caused her to be unable to talk or speak for a few seconds.  She was brought back down to the hall for evaluation.  She felt as if she was having a stroke and that got her more worked up.  She denies lower body weakness.  She states that her head feels heavy and she complains of general fatigue.  No n/v.  No headache or blurry vision.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date, not supported VAQTA (dose, therapy route, anatomical location, lot #, expiration date were not reported) was administered post excursion of -2.3 Celsius degree for 10 hours. This is the one of several reports from the same reporter source. Additional information has been requested.
Indentation to right thigh (anterior) of 1/2cm with lightening of skin color; Mom states she received immunization in that area in March.
Pt. states that after receiving the 1st dose of Phizer 06/23/2021, woke up 06/24/2021 with extreme vertigo and cracking sound inside the back-side of the head. noted with Physician visit, prescribed HBP Metoprolol. ENT exam noted swelling in inner-ear and surrounding area. Prescribed Amoxicillin. Feeling of her head is under water and tension - on the left side.
MenQuadfi was inadvertently administered to a 14-year-old male patient who had already received his Menveo vaccine at age 13. No side effects noted.
Leg pain. Started in calf. Moved to hamstring. Moved to glutes; Leg pain. Started in calf. Moved to hamstring. Moved to glutes; Leg pain. Started in calf. Moved to hamstring. Moved to glutes; This is a spontaneous report received from a Non-contactable consumer (Patient). This 52-year-old female (non-pregnant) consumer reported for herself that she received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EP7533) via an unspecified route of administration into the left arm on 07Apr2021 09:30 AM (at the age of 52-year-old) at single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient medical history included allergies to medications, food, or other products. Others included EGPA, asthma, bronchiectasis, vasculitis, eosinophilic granulomatosis with polyangiitis, aspirin [acetylsalicylic acid], iodine and antibiotics all for drug hypersensitivity. The patient concomitant medications included medications that the patient received within two weeks of vaccination which included mepolizumab (NUCALA), prednisolone acetate (PRED+), cetirizine hydrochloride (ZYRTEC ALLERGY), atorvastatin (LIPITOR [ATORVASTATIN]), diltiazem (CARDIZEM [DILTIAZEM]), budesonide, formoterol fumarate (SYMBICORT). On 08Apr2021 05:00 PM, the patient reported of leg pain which started in calf, moved to hamstring and moved to glutes. The patient did not receive treatment nor any other vaccines within four weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. The outcome of events was recovering for all the events.  No follow-up attempts are possible. No further information is expected
All of this started at the end of the 30-minute wait period (for those of us with prior anaphylactic reactions...mine was due to a wasp), and I left and went back because my symptoms were disconcerting.  Had to get the parents to pick the car and me up after being monitored and dosed with Benadryl and almost hit with an epipen because my face was swelling (nose, lips, roof of my mouth to the point that my lips felt as if they would pop), BP and heartbeat elevated, and I itched from my shoulders up.
woke next morning w/ temp. 100.8 fever; full body aches; left armpit swollen / sore (inj. arm); left armpit swollen / sore (inj. arm); extreme shaking last 2-3 hours; severe headache; eye ache; administration date of dose 1: 11Jan2021/ administration date of dose 2: 28Jan2021; This is a spontaneous report from a contactable consumer (patient). A 62-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3249 and expiration date not provided), via an unspecified route of administration left arm second dose on 28Jan2021 at single dose for Covid-19 immunization. The vaccine was administered in the hospital. The Patient's medical history included Esophageal Cancer. The patient's concomitant medications were not reported. The patient historical vaccine includes BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EJ1686 and expiration date not provided) via an unspecified route of administration left arm first dose on 11Jan2021 for Covid-19 immunization. On 28Jan2021 17:30, the patient experienced extreme shaking last 2-3 hours, severe headache, eye ache, full body aches, left armpit swollen/sore (injection arm). Woke next morning 29Jan2021 with temperature 100.8 fever, later evening, temperature of 99.6. Symptoms lasted almost 72 hours. The patient stayed in bed the entire time. The patient did not received treatment for the events.  The outcome of the events was recovered.  The reporter assesses the events as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.
PATIENT STATES THAT SHE HAS HAD A HEADACHE SINCE RECEIVING THE SHOT 6 DAYS AGO.  She said there is a lot of pressure in her scalp.  She has been taking otc pain relievers without much relieve.    Recommended that she seek medical care as soon as possible
tested positive for Covid-19; A spontaneous case was received to the safety reporting that patient had his 1st dose of the Moderna Covid-19 vaccine on 28Dec2020 at a healthcare facility. He had it on his left arm with unknown dose and route of administration. Lot number and expiration date were not provided. On 01Jan2021, he tested positive for Covid-19. He went ahead to get the 2nd dose which was given on 24Jan2021 in the same facility. It was administered on his left arm with unknown dose and route of administration. Lot number and expiration date not provided. Consent to follow up obtained.
Patient was admitted to Medical Center on 8/11/21 in respiratory distress. Patient expired on 8/24/21 vaccine dates were 1st dose Pfizer vaccine on 7/14/21 2nd dose 8/4/21.
Had pain at the injection site and also at the top of my shoulder and in my armpit that I noticed when I woke up. Became extremely nauseous at 5:00 PM.  Went to bed and woke up the next morning (11/12/16) and was no longer nauseous but noticed red blothces that extended midway down my arm, to my shoulder and my neck. The blotches were not puffy like hives and when I touched the areas that were red they were painful.  I went to another store and showed the pharmacist who said that she had another patient eith a similar reacion.
Tired; Sleepy; Sore; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05May2021 at 12:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05May2021 at 13:00, the patient experienced tired, sleepy and sore. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tired, sleepy and sore was unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
On the morning of 1/12/2021 I had some itching on bilateral elbows and some faint red raised areas on my thighs that were not pruritic. I was able to go to work, however towards the end of the day around 4pm more formal appearing hives appeared on my hands and pruritis increased throughout. I went home at the end of the workday and did a full body skin assessment. I had hives on bilateral arms and legs and several on my face. Pruitis was moderate to severe. I took 50mg of Benadryl and proceeded to the Emergency Department because it seemed to be getting worse quickly and I did not have any other interventions (epi-pen or steroids) on hand at my home.
shingles; This spontaneous report was received from a company representative who refers to an 81-year-old female patient (her mother). Pertinent medical history, drug reactions, allergies and concomitant medications were not reported.   On 01-JAN-2007, the patient was vaccinated with the first dose of zoster vaccine live (ZOSTAVAX) (lot number, expiration date, dose and route of administration were not reported). On 30-APR-2007, she was vaccinated with the second dose of zoster vaccine live (ZOSTAVAX) (lot number, expiration date, dose and route of administration were not reported). Concomitant therapies included sterile diluent.  On 18-JUN-2019 (reported as 6 days ago), an itchy rash appeared. The rash presented unilaterally as small blisters on the patient's left ankle and left lower back and she complained of fatigue. The patient had no fever or headache. A doctor at urgent care confirmed she had shingles.  The outcome of shingles was unknown.  The relatedness between shingles and the vaccine was not reported.
Information has been received from a registered nurse referring to a patient of unknown age and gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions reported. On 28-SEP-2015, the patient was vaccinated with ZOSTAVAX (0.65 ml, Lot#L024997, expiration date: 06-OCT-2016), which was improperly stored for 14 days (Incorrect product storage). The outcome was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report was received from a certified medical assistant concerning fifteen patients of unknown ages and genders. The patients concurrent conditions and medical histories were not reported. On an unknown dates, fifteen patients were vaccinated with improperly stored doses of VAQTA, lot # K005323, expiration date: 10-FEB-2017 (frequencies, doses, strengths, routes and expiration dates were not reported). Co-suspect therapies or concomitant medications were not  provided. No adverse symptoms reported. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a 60 year old female patient with drug reaction/allergy to sulfa. Other medical history was not reported. On 16-NOV-2014, the patient was vaccinated with ZOSTAVAX lot # K008880 expiry date 20-SEP-2015 (also reported as 09-SEP-2015), 0.65 ml, intramuscular (not sure if it was administered intramuscular) in the arm. Concomitant medication was not reported. In November 2014, after receiving ZOSTAVAX, the patient experienced red swollen lump on an unspecified part of her arm. Where the lump was located at, the reporter though ZOSTAVAX might have been administered intramuscularly, but was not sure. No treatment given for the events. No lab diagnostics performed. The patient went to the pharmacy on 21-NOV-2014 to show the pharmacist her symptoms. At the time of the report, action taken regarding therapy with ZOSTAVAX and the outcome of red swollen lump on arm were not reported. Additional information has been requested.
*MMRV given per the Nurse Practitioner orders. -unaware it cannot be given after age 12.
Patient was driving back to work. Became tachycardic during the drive and pulled over to a local pharmacy. She self administered 50mg of diphenhydramine and took her blood pressure at the pharmacy. The BP was found to be elevated. EMS picked the patient up and transported her to ED.
Patient called and said she had swelling in her knuckles, rash on the inside of the elbows and a welt on her skin. She said she did not seek medical treatment. By Monday all the symptoms were gone.
evening of 17DEC96 fussy & inc temp unk degree, went down w/APAP;18DEC96 pt cried alot, temp stayed down until evening that evening had high pitched cry >1hr & 101.9 temp;saw MD 19DEC96 1PM for sx & also had throat infect;
Nervous system impairment severe dizziness syncope no balance 12 days as impatient, received solumedrol antivert and 5 doses of IVIG
These are the initial side effects that occurred immediately after each injection, daily tingling above my upper lip, as if I were about to get a cold sore, and occasional curling of my upper lip. I also experienced very deep sleep accompanied by severe disturbing dreams. These side effects continued for over a month after the shots.  The following side effects occurred a couple of months later. Swelling of lymph glands on the left side of my face. Throat aching. Blood in my urine. Kidney pain and discomfort. Currently in the process of exploring severity of the condition.
patient had  1st dose of Moderna vaccination on 3/31/2021 and 2nd dose of moderna on 4/28/2021.I am his PCP cam e to me c/o of body aches , congestion, mild fever. I felt it the symptoms were more viral  so I adviced hime to get COVID test, he called  me back and told me he got tested positive . Hi Family doesn't have symptoms at all.
pt recv vax 18SEP96 & on 3MAR97 pt devel chickenpox consisting of greater than 50 lesions;pt also devel hives & strep throat;
Information has been received from a registered nurse concerning a female who was vaccinated PO with a third dose of Rotateq. Subsequently, about a month after vaccination, the patient experienced intussusception. It was noted that the patient had surgery, but no additional information was available. There was no product quality complaint. Intussusception was considered to be immediately life-threatening and disabling and an other important medical event. Additional information has been requested. 05/02/07-records received for DOS 04/15-04/17/07-DC DX:Intussusception. Presented with sudden onset of emesis and bloody stool. Barium enema and attempt to reduce radiologiclly was unsuccessful. Surgery laprascopic reduction and appendectomy.
Body aches, low grade fever, fatigue, site of injection was red, swollen, warm to touch
Initial misuse report received from a healthcare professional on 11 February 2014. It was reported that the patient (in child age group) (no information was provided regarding the patient) had received only DTAP/IPV portion of PENTACEL on an unspecified date. No adverse event was reported. Documents held by sender: none.
approx 2yrs p/vax pt devel chickenpox w/more than 50 generalized lesions.
Pt diffuse reddness around injection site of lt deltoid /p inject.  Developed low abdominal groin discomfort
I have had extreme diarrhea since getting the shot and don't want to leave home for fear there won't be a bathroom close by. I've had to have more bathroom breaks at work also. I have made an appointment with my Dr. but can't get in till August 17. I have felt like I was going to throw up and have a few times.
approx 7 minutes p/MMR inject rt thigh, rt thigh had 70x65 mm reddened sl swollen area; top margin of this area raised; ice pack applied & pt observed x 1/2 hr;
ARM PAIN, FEVER CHILLS, NAUSEA VOMITING, DEVELOPED ESOPHAGEAL ULCER THAT REQUIRED SERIAL UPPER ENDOSCOPY.  OVER NEXT SEVERAL MONTHS TO PRESENT DATE HAS HEARING LOSS, FATIGUE, HEADACHE, UPSETTING DREAMS, OCCASIONAL GI UPSET, INANITION